Blossom Blog · Jun 2026
Blossom published outcomes data on 8,635 patients and 42,592 assessments, reporting measurable PHQ-9 and GAD-7 improvement over repeated visits.
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Blossom Health is a New York-based virtual psychiatry company that combines insurance-covered therapy and medication management with proprietary software and AI agents to help patients access faster, more affordable psychiatric care.
Primary product
AI operating system for psychiatry
Founded
2024
Headquarters
169 Madison Avenue, Suite 15318, New York, NY 10016, United States
Team size
11-50
Work style
Flexible
Industry
Technology, Information and Internet
Sub-industry
Digital health / telepsychiatry
Offices
0 jobs at Blossom
Check back later for new openings
Business model
Stage
Series A
Total raised
$38.4M
Latest round
Series A · Mar 2026
Latest amount
$20M
Mar 2026 · Headline
Oct 2025
Jun 2024
Leadership
Founder & CEO
Head of Engineering
Head of Partnerships and Strategy
Head of Field Marketing & Operations
Medical Director
Investors
High-velocity, ownership-driven startup culture that explicitly rejects a 9-to-5 mindset and emphasizes intensity, commitment, autonomy, and high excellence.
Work style
Flexible
Visa sponsorship
No
Compensation
Public postings show $100K-$150K plus equity for Partnerships Strategy & Ops, $100K-$200K plus equity for GTM Revenue Operations, and $250K-$500K for Psych Nurse Practitioner roles, with clinician upside and no provider fees.
Benefits
Pricing
Insurance-reimbursed, in-network copay model; most patient copays are $0-$22.
Differentiators
Technology
Customers
Competitors
Blossom Blog · Jun 2026
Blossom published outcomes data on 8,635 patients and 42,592 assessments, reporting measurable PHQ-9 and GAD-7 improvement over repeated visits.
Blossom LinkedIn · Jun 2026
Blossom highlighted a Wall Street Journal feature and reiterated its focus on reducing administrative work for psychiatrists with AI.
PRNewswire · Mar 2026
Blossom announced a $20M Series A/Seed funding package, with Headline leading the Series A and returning investors including Village Global and TA Ventures.
Fortune · Mar 2026
Fortune reported Blossom's $20M fundraise and framed the company as an AI-native psychiatry platform aimed at scaling care without large staff growth.
Blossom Blog · Feb 2026
Blossom and Thriveworks announced a two-way referral partnership linking virtual psychiatry with therapy and in-person care across 340+ Thriveworks locations.